| About ResearchNet | Français |
|
|
| Home | FAQ | Contact Us | Sign-In |
| Search Again | Print Preview | Notify a Colleague |
| Funding Opportunity Details | ||||||||||
|
Important Dates | ||||||||
|
NoticesThe content of this funding opportunity has been updated Date updated: 2009-01-22 Sections updated: Objectives (Clinical Research) |
Table of Contents
Description
Priority Announcements on Fellowship competitions offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas or mandates. Applications are submitted through the February 2009 (2009-02) competition of the Fellowship: 2008-2009 funding opportunity. Fellowships provide support for highly qualified candidates at the post-PhD or post-health professional degree stages to add to their experience by engaging in health research either in Canada or abroad. Funds Available CIHR's contribution to the amount available for this initiative is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them. Funds Available for Research in All Areas: Funds are available for applications in all areas of research that address any important health problem or issue through the February 2009 (2009-02) competition of the CIHR Fellowship: 2008-2009 funding opportunity. Funds Available for Research in Specific Areas: In this competition, funds are available to encourage and support applications in specific areas that are aligned with CIHR's research priority areas and mandates. Information on the research areas to be funded and financial information are found in the "Objectives" section. A. CIHR Research Priority Areas
B. Prizes in CIHR Research Priority Areas
Top Objectives
The specific objective of the Fellowship Priority Announcement (Specific Research Areas) is to offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas and mandates. A. CIHR Research Priority Areas 1. Aging - Longitudinal Studies. CIHR, under the Canadian Longitudinal Study on Aging (CLSA) initiative, will fund applications that are determined to be relevant to the research priority areas described below:
More information on the objectives and relevant research areas is available on the Canadian Longitudinal Study on Aging Fellowships webpage. CIHR-IA will evaluate applications for relevance to the research priorities which must be addressed within one relevance form (see "How to Apply").
Additional Information:
For questions about this initiative and research objectives contact: Sharon Nadeau, Associate, Strategic Initiatives, CIHR –IA For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 2. Aging - Mobility in Aging. The CIHR Institute of Aging (CIHR-IA) will fund applications that are determined to be relevant (2) to the research priority areas described below: CIHR-IA will evaluate applications for relevance to the Mobility in Aging Initiative priority areas which must be addressed within one relevance form (see "How to Apply").
Additional Information:
For questions about this initiative and research objectives contact: Sharon Nadeau, Associate, Strategic Initiatives, CIHR –IA For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 3. Amyotrophic Lateral Sclerosis. The Amyotrophic Lateral Sclerosis Society of Canada - ALS Canada in partnership with the CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA) will fund applications that are determined to be relevant to the research priority areas described below:
More information on the research priorities of the Amyotrophic Lateral Sclerosis Society of Canada on their Website.
Additional Information:
For questions about this initiative and research objectives contact: Barbara Beckett, Assistant Director, CIHR-INMHA For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 4. Clinical Research. The National Strategy on Patient-Oriented Research will fund applications that are determined to be relevant to the research priority area described below:
The maximum amount awarded for a single award is up to $60,000 per annum for up to five years. The CIHR anticipates that two awards will be offered through this competition. This priority announcement is directed to licensed health professionals (3) engaged in clinical research. Candidates must hold a valid Canadian license (full or educational) at the time of application. Canadian licensure must be maintained for the duration of the award. Clinical Research is that part of the continuum of health research which is conducted on humans or on materials, specimens, or data derived from humans and populations with a focus on:
In addition, clinical research may utilize the methods of health care services/systems research and population health research as they relate to clinical encounters. Additional Information:
For questions about this initiative and research objectives contact: Tammy Whynot, Project Officer (Updated: 2009-01-22) For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 5. Drug Policy (Ontario). The Ontario Ministry of Health and Long-Term Care (MOHLTC) in partnerships with the CIHR Institute of Health Services and Policy Research (CIHR-IHSPR) will fund applications that are determined to be relevant to the research priority area described below:
The Ontario Public Drug Programs (OPDP) (4) of the Ontario Ministry of Health and Long Term Care is funding these Fellowships through the Drug Innovation Fund, a key initiative of the Ontario Government's plan to reform the provincial drug system. The OPDP's main area of interest is the impact of drugs on health outcomes, non-drug health system outcomes and costs. Please refer to the IHSPR website for more information on this priority research area.
Additional Information:
For questions about this initiative and research objectives contact: Krissy Davidge , Associate, Strategic Initiatives, CIHR-IHSPR For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 6. HIV/AIDS. The CIHR Institute of Infection and Immunity - HIV/AIDS Research Initiative will fund applications that are determined to be relevant to the research priority areas described below:
More information on the research priorities of the HIV/AIDS Research Initiative can be found on the Institute of Infection and Immunity website. Research in the priority areas described above that focuses on at risk populations including people living with HIV/AIDS, men who have sex with men, injection drug users, Aboriginal Peoples, prison inmates, youth at risk, women at risk and people from countries where HIV is endemic is encouraged. The maximum amount awarded for a single award is up to $60,000 per annum for up to five years. CIHR anticipates that four awards will be funded through this competition. Additional Information:
For questions about this initiative and research objectives contact: Jennifer Ralph For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 7. Knowledge Translation. CIHR will fund applications that are determined to be relevant to the research priority areas described below:
CIHR's mandate is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system. The purpose of this funding opportunity is to further strengthen knowledge translation (synthesis, dissemination, exchange and ethically sound application of knowledge) by supporting knowledge translation trainees early in their careers. It is expected that this targeted investment will lead to a better understanding of concepts, theories and practices that underlie effective KT in order to improve the health of Canadians, provide more effective health services and products and strengthen the health care system.
More information on the research priorities of the CIHR Knowledge Translation Portfolio can be found on their website. Additional Information:
For questions about this initiative and research objectives contact: Andrea Smith For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 8. Regional Partnerships Program - Manitoba (RPP- Man). CIHR, through the Regional Partnerships Program (RPP), in partnership with Manitoba Health Research Council may fund applications in Manitoba in all four themes of research, subject to funding ability. The maximum amount awarded for a single award is up to $55,000 per annum for up to two years. One award is expected to be offered through this competition (subject to the availability of funds). Additional Information:
Please note researchers must submit their applications at least two weeks prior to the CIHR deadline to have their applications vetted by the internal review procedures at MHRC in order for their award to be eligible for consideration for RPP funding. When applying through ResearchNet, please ensure to select RPP- Manitoba in the drop-down menu of the priority announcement. For additional information on eligibility criteria and funding details, please contact: Shannon Rogalski For questions about this initiative and research objectives contact: Erik Blache, Senior Advisor, Partnerships and Citizen Engagement, CIHR For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 9. Regional Partnerships Program - New Brunswick (RPP- NB). CIHR, through the Regional Partnerships Program (RPP), in partnership with New Brunswick - RPP may fund applications in all four themes of health research that contribute to the goal of building health research capacity in New Brunswick, which meet RPP eligibility requirements. More information on the research priorities of New Brunswick can be found on their website. The maximum amount awarded for a single award is up to $55,000 per annum for up to five years. Additional Information:
For eligibility guidelines, see the New Brunswick- CIHR RPP program description. When applying through ResearchNet, please ensure to select RPP-New Brunswick in the drop-down menu of the priority announcement. Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures of the New Brunswick RPP Advisory Board a minimum of two weeks prior to submitting their application to CIHR in order for their award to be eligible for consideration for RPP funding. For questions about the NB RPP Advisory Board review process and criteria, please contact: John Boyne For questions about this initiative and research objectives contact: Erik Blache, Senior Advisor, Partnerships and Citizen Engagement, CIHR For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 10. Regional Partnerships Program - Newfoundland and Labrador (RPP- NL). CIHR, through the Regional Partnerships Program (RPP), in partnership with Newfoundland and Labrador - RPP may fund applications in all four themes of health research in Newfoundland and Labrador, pending funding availability, which meet RPP eligibility requirements. More information on the research priorities of Newfoundland and Labrador can be found on their website. The maximum amount awarded for a single award is up to $55,000 per annum for up to two years. Approximately four awards are expected to be offered through this competition (subject to the availability of funds). Additional Information:
Please note that researchers must submit their applications at least one month prior to the CIHR application deadline to have their applications vetted by the internal review procedures at RPP- Newfoundland and Labrador in order for their grant to be eligible for consideration for RPP funding. Contact for this process is: Office of Research and Graduate Studies For questions about this initiative and research objectives contact: Erik Blache, Senior Advisor, Partnerships and Citizen Engagement, CIHR For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 11. Regional Partnerships Program - Prince Edward Island (RPP- PEI). CIHR, through the Regional Partnerships Program (RPP), in partnership with Prince Edward Island - RPP may fund applications that span the four themes of research that contribute to the goal of building health research capacity in PEI. The following areas of research strength at UPEI reflect the four themes:
More information on the research priorities of Prince Edward Island can be found in the University of Prince Edward Island Strategic Plan. The maximum amount awarded for a single award is up to $55,000 per annum for up to two years, dependant on the number of applicants. Additional Information:
For eligibility guidelines, see the PEI - CIHR RPP program description. Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures at the PEI Health Research Institute a minimum of one month prior to submitting their application to CIHR in order for their award to be eligible for consideration for RPP funding. For more information, please contact: Leslie Cudmore For questions about this initiative and research objectives contact: Erik Blache, Senior Advisor, Partnerships and Citizen Engagement, CIHR For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 12. Regional Partnerships Program - Saskatchewan (RPP- Sask). CIHR, through the Regional Partnerships Program (RPP), in partnership with Saskatchewan - RPP may fund highly rated applications in Saskatchewan in all four themes of research, subject to funding availability. Fellowships awarded to health professionals for the purpose of doctoral training will be funded for up to three years. Post-doctoral fellows (PDFs) will be funded for up to two years. PDFs who have already received a 2-year award from the Saskatchewan Health Research Foundation (SHRF) Research Fellowship Program will only be supported for one year. The awarded funding will be established at the appropriate minimum amounts set by CIHR regulations. An award is usually made for one year with a requirement to re-apply to CIHR. Renewal is automatic if the re-application is considered fundable by CIHR (i.e. 3.5 or greater rating). Otherwise the awards are not renewable. For additional information on eligibility criteria and funding details, please refer to Saskatchewan-CIHR RPP Policies. Additional Information:
For questions about this initiative and research objectives contact: Erik Blache, Senior Advisor, Partnerships and Citizen Engagement, CIHR For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 13. Transfusion Science. The CIHR Institute of Circulatory and Respiratory Health and Canadian Blood Services (CBS) will fund applications that are determined to be relevant to the research priority areas described below:
More information on the research priorities of the CIHR-Institute of Circulatory and Respiratory Health and the Canadian Blood Services can be found on their websites.
Additional Information:
For questions about this initiative and research objectives contact: Katherine Gardner, Project Manager, CIHR-ICRH For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. B. Prizes in CIHR Research Priority Areas 14. Aging - CIHR Institute of Aging Fellowship Recognition Prize in Research on Aging. The CIHR Institute of Aging (CIHR-IA) aims to advance knowledge in the field of aging to improve the quality of life and the health of older Canadians. With this goal in mind, CIHR-IA has been investing in the future of research on aging by developing and supporting capacity-building research initiatives and programs to train support new and emerging researchers in the field of aging. The CIHR-IA Fellowship Recognition Prize in Research on Aging
Additional Information:
For questions about this initiative and research objectives contact: Sharon Nadeau, Associate, Strategic Initiatives, CIHR –IA For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 15. BIOTECanada Schering-Plough Canada. One award will be offered to the highest ranking candidate who applies to one of the two Fellowship Award competitions each year (October and February), whose research focus is in one or more of the following areas: immunology, infectious and inflammatory diseases, cardiovascular conditions, allergies and/or respiratory problems and who is ranked highly enough to be approved for a regular CIHR Fellowship Award. The CIHR BIOTECanada Schering-Plough Canada Fellowship consists of a $5,000 supplement to the stipend and a $5,000 supplement to the research allowance of a regular Fellowship Award. The supplement to the research allowance is intended to be used mainly for travel to national or international conferences, workshops or meetings related to immunology, infectious and inflammatory diseases, cardiovascular conditions, allergies and respiratory problems research. Additional Information:
For questions about this initiative and research objectives contact: Annik Poirier, Team Lead, Program Delivery, CIHR For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 16. Bisby Fellowship. Dr. Mark Bisby joined the former Medical Research Council of Canada in 1997 as Director of the Programs Branch. From his arrival in 1997 to his retirement in June 2006, he played an important liaison role with Canada's research community, firstly in ensuring that there was a smooth transition between MRC and CIHR and then creating an environment of research excellence to cultivate the broadened research mandate of CIHR. In honouring Dr. Bisby's commitment to CIHR and the health research community, CIHR offers Fellowship Awards in his name. An award will be offered to the highest ranking candidates in each of the Fellowship committees in each CIHR Fellowship competition. In addition to receiving the applicable stipend and a research allowance under the fellowship program, awardees will carry the distinction of being branded a Bisby Fellow and will receive a supplement to the research allowance of an additional $5,000. The intent of the additional research allowance is to enable recipients to assert themselves as thought leaders on the national and international research stage through engagement in national or international conferences, workshops or meetings related to the award recipient's research. For questions about this initiative and research objectives contact: Annik Poirier, Team Lead, Program Delivery, CIHR For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 17. Cancer. Jean-François St-Denis, PhD (August 14, 1966 - March 2, 2004) joined the Canadian Institutes of Health Research (CIHR) in 2000, after completing a PhD at the University of Montreal and postdoctoral studies at the National Institutes of Health in Bethesda, Maryland and the Hospital for Sick Children in Toronto. CIHR is pleased to honour Dr. St-Denis' courageous struggle against cancer by offering a Fellowship Award in his name. This award is offered to an outstanding individual who is to undertake postdoctoral training in the field of cancer research. One award will be offered to the highest ranking candidate who applies to one of the two Fellowship Award competitions each year (October and February), whose research focus is on cancer and who is ranked highly enough to be approved for a regular CIHR Fellowship Award. The CIHR Jean-François St-Denis Fellowship consists of a $5,000 supplement to the research allowance of a regular Fellowship Award. The supplement to the research allowance is intended to be used mainly for travel to national or international conferences, workshops or meetings related to cancer research. Additional Information:
For questions about this initiative and research objectives contact: Annik Poirier, Team Lead, Program Delivery, CIHR For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 18. Huntington Disease. The Huntington Society of Canada (HSC) in partnership with the CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA) will fund applications that are determined to be relevant to the research priority area described below.
More information on the research priorities of the Huntington Society of Canada can be found on their website.
The award winner will be the highest-ranked eligible candidate from the October 2008 and February 2009 open Fellowship competitions. Eligible candidates from the October 2008 and February 2009 competitions will be identified through a keyword search. Additional information:
For questions about this initiative and research objectives contact: Barbara Beckett, Assistant Director, CIHR-INMHA For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 19. Knowledge Translation - Elizabeth Dickson KT Fellowship Supplement. This award supplement is offered to an outstanding individual who is to undertake postdoctoral or post health professional training in the field of Knowledge Translation. A supplement will be offered to the highest ranked and funded candidate from the February 2009 Fellowship Award competition who has applied to, and been deemed relevant for, the Knowledge Translation Priority Announcement. The Elizabeth Dickson KT Fellowship Supplement consists of a $5,000 supplement to the research allowance of a regular Fellowship Award. The supplement to the research allowance is intended to be used mainly for travel to national or international conferences, workshops or meetings related to the award recipient's research. Dr. Elizabeth Dickson played a key role in the launch of the CIHR in the year 2000, leading efforts to meet critical milestones in the mandated transformation. For more information on this supplement, see the Knowledge Translation web site.
In addition to the standard KT activities of presenting research findings to targeted audiences and producing lay summaries for dissemination, recipients of the KT award supplement are expected to undertake one of the following activities:
Associated costs will be covered by CIHR and activities will be undertaken in coordination with the Knowledge Synthesis and Exchange Branch. Additional Information:
For questions about this initiative and research objectives contact: Andrea Smith For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 20. Mood Disorders. (Mona Bronfman Scheckman (Prize)/ CIHR-INMHA Fellowship Award).The Canadian Psychiatric Research Foundation (CPRF) and the CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA) will fund applications that are determined to be relevant to the research priority areas described below: Mood disorders including the following research areas:
More information on the research priorities of the Canadian Psychiatric Research Foundation, and CIHR-INMHA can be found on their websites. The award winner will be the highest-ranked eligible candidate from the October 2008 and February 2009 open Fellowship competitions. Eligible candidates from the October 2008 and February 2009 competitions will be identified through a keyword search. The recipient must be undertaking full-time research training in Mood Disorders at the Centre for Addictions and Mental Health (CAMH) located in Toronto.
Additional Information:
For questions about this initiative and research objectives contact: CIHR - Partnerships and Citizen Engagement Branch CIHR-INMHA CPRF For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 21. Schizophrenia. In 1993, Dr. Michael Smith received the Nobel Prize for Chemistry in 1993 for his discovery and development of a crucial technique known as site-directed mutagenesis, used in genetic engineering. His discovery enabled researchers to gain enormous insights into the structure and function of genes and proteins. Throughout his career, Dr. Smith strongly encouraged young people to pursue science as a career, and he has used his prize to promote science, encourage women to pursue interests in science and support research on severe mental illnesses, especially schizophrenia. To honor Dr. Smith's scientific accomplishments and his lifelong promotion of science, CIHR offers a Doctoral Research Award in his name (CIHR Michael Smith Fellowship Award for Research in Schizophrenia). To be considered eligible for this award, the application must be relevant to the research priority areas described below:
Additional Information:
For questions about this initiative and research objectives contact: Annik Poirier, Team Lead, Program Delivery, CIHR For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. Top Eligibility
Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions. Specific to CIHR training awards, please refer to the General Guidelines for Training Programs, as well as the Fellowship: 2007-2008 funding opportunity. Top Guidelines
This funding opportunity will follow the General Guidelines for Training Programs. Applicants are encouraged to demonstrate the use of Gender and Sex-Based Analysis in applications. Allowable Costs The awards consist of a stipend and a research allowance. For the research allowance, awardees should review the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC and SSHRC) Financial Administration Guide for a complete listing and description of allowable costs and activities. Conditions of Funding All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through this funding opportunity. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official languages policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR's Support. Successful applicants will be informed of any special financial requirements prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document. Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA) All personal information collected by CIHR about applicants is used to review applications, to recruit reviewers, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review. CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR's premises including, without limitation, cost-sharing agreements related to this funding opportunity and all matters pertaining thereto. While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the Funding opportunity will be collected, used and disclosed in compliance with the PIPEDA. CIHR Guidelines for Health Research Involving Aboriginal People The CIHR Guidelines for Health Research Involving Aboriginal People came into effect as policy for CIHR-funded research on July 1, 2008. Applicants whose proposed research will involve Aboriginal People are strongly encouraged to familiarise themselves with these guidelines and in particular with the section "Application of the Guidelines," which outlines the situations in which these guidelines apply. Communication Requirements Grant recipients are required to acknowledge CIHR, its institutes and partners in any communication or publication related to the project. See CIHR General Grants and Awards Policies, Public Communication and Acknowledgement of CIHR's Support for details on CIHR's communication requirements. The contributing institutes / partners will be identified on the Authorization for Funding and decision letter. Top Performance Measurement
CIHR is committed to demonstrating results to Canadians for the money invested in health research. Therefore, processes for monitoring progress and appropriate use of funds, as well as for performance measurement and program evaluation are in place. As a result, funding recipients must:
Top Review Process and Evaluation
Relevance Review A. CIHR Research Priority Areas: CIHR and partner organizations will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described under "CIHR Research Priority Areas" within the "Objectives" section. Relevance of the applications to the research priorities will be determined in the following manner. Prior to peer review, CIHR and the partner organizations will review applications to determine the relevance, or alignment, of the research proposed to the research priority area(s) described above. To conduct relevance review, these representatives will have access to a completed relevance form in addition to anonymized project titles and summaries, provided that applicants have consented to the sharing of information in consideration for other funding opportunities as well as to the sharing of information to observers in completing their ResearchNet application. Upon completion of peer review, the CIHR and the partner organizations will receive the ratings, rankings and peer review committee recommendations on funding level and grant or award term for those applications that 1) are found to be relevant to the specific objectives of the research initiative and the research priority areas described under "CIHR Research Priority Areas"; and 2) are rated within the CIHR fundable range but are not funded through the regular CIHR competition to which they were submitted. These applications will be funded from the top down in order of ranking as far as budgets will allow. Applications that receive a ranking below 3.5 will not be funded. Applications deemed relevant to a priority announcement, which are funded in the regular Fellowship competition or through a priority announcement will be named "Fellowship in the area of [specific research area] research" (e.g., Fellowship in the area of aging research). Peer review committees will not be informed of applications submitted for funding through this announcement. B. Prizes in CIHR Research Priority Areas: Upon completion of peer review, representatives of CIHR and/or partner organizations will receive an anonymized ranking list, funding level and peer review committee recommendations on award term for all applications 1) that are funded in the regular CIHR Fellowship competition(s); and 2) that are identified as relevant through a keyword search. This information will be used to conduct relevance review when required and to determine the recipient(s) of the prize(s). These applications will be selected from the top down in order of ranking as far as budgets will allow. Applications that receive a rating below the regular CIHR Fellowship competition cut-off will not be considered for prizes. Peer review committees will not be informed of applications submitted for funding through this announcement. Peer Review A CIHR peer review committee will evaluate the full applications. The committee may be drawn from one of CIHR's pre-existing committees or may be created specifically for this funding opportunity. Committee members are selected based on suggestions from many sources including the institute(s) / portfolio(s) and partner(s), following CIHR's Policy on Conflict of Interest and Confidentiality in the context of Merit, Relevance and Peer Review (CCIP). Evaluation Criteria Fellowship Awards are reviewed in accordance with the Guide for Reviewers – CIHR Fellowships. The following general criteria for evaluating training award applications will be used:
Top How to Apply
Note: This funding opportunity requires the use of ResearchNet to apply for funding.
Additional instructions that must be followed for this funding opportunity: A. CIHR Research Priority Areas
B. Prizes in CIHR Research Priority Areas:
Top Contact Information
For questions on CIHR funding guidelines, how to apply, and the peer review process contact: Annik Poirier
Top Additional Information
1. Aging. CIHR-IA will evaluate for relevance using the following criteria which must be addressed in separate paragraphs within the relevance field of your ResearchNet application:
2. Aging - Mobility in Aging. CIHR-IA will evaluate applications for relevance using the following criteria which must be addressed in separate paragraphs within one relevance form (see "How to Apply"):
3. Clinical Research. List of CIHR-Eligible Health Professions:
Notes:
4. Drug Policy (Ontario). Ontario Ministry of Health and Long-term Care - Ontario Public Drug Programs (OPDP): Through the Transparent Drug System for Patients Act (formerly known as Bill 102), the Ontario Government has committed to provide annual funding for innovative health system research through the establishment of the Drug Innovation Fund. Short-term and multi-year funding will be provided to eligible researchers and organizations in Ontario to support evidence-based research on the impact of drugs on patient outcomes and health system outcomes (including non-drug expenditures) in Ontario in order to support drug policy decision making in the province. Capacity building and knowledge transfer are also important objectives of the Fund. The mandate of the funding program is to:
Top |
| Search Again | Print Preview | Notify a Colleague |
| Support |
 For technical problems, please contact us at 613-941-9080 or by e-mail at support@researchnet-recherchenet.ca, Monday-Friday from 8:30 a.m. to 4:30 p.m. Eastern Time. |
| Important Notices | © 2004-2007 CIHR-IRSC |